- In April 2025, Alcon Research, LLC. received U.S. FDA approval for its UNIPURE C3F8 Ophthalmic Gas, designed for injection into the eye to treat uncomplicated retinal detachment. This product, to be commercially available in 2025, utilizes Alcon's UNIFEYE or UNIPEXY Gas Delivery Systems. This highlights advancements in specific, targeted disposable solutions for retinal conditions
- In June 2024, C3 Med-Tech received Rs. 2 crores (USD 0.24 million) from Industrial Metal Powers India Pvt Ltd. to develop AI-enabled portable ophthalmic devices for telemedicine. This initiative aims to enhance eye checkups and real-time disease detection, emphasizing the increasing integration of AI and disposable components in diagnostic tools for remote care
- In June 2023, Bausch + Lomb Launches INFUSE Multifocal Daily Disposable Contact Lenses: Bausch + Lomb Corporation launched its INFUSE Multifocal silicone hydrogel (SiHy) daily disposable contact lenses in the U.S. These lenses are designed to offer comfort and clear vision for patients with presbyopia, indicating a continued push for advanced daily disposable contact lens solutions
- In August 2023, Johnson & Johnson Vision presented its Elita laser correction device in the U.S. launch. This platform is described as revolutionary for correcting short-sightedness through a minimally invasive laser-assisted lens removal procedure. While a device, it likely leverages various disposable components for sterility and precision during surgery.
- In April 2023, Canadian eye health company Bausch + Lomb announced the launch of these two products in the U.S.. StableVisc and TotalVisc provide eye surgeons with new options for dual-action protection during cataract surgery, indicating ongoing innovation in disposable surgical aids
- In January 2022, Alcon introduced its Dailies Total1 for Astigmatism, the company's third disposable water gradient contact lens for U.S. patients. This further expands the range of daily disposable options catering to specific vision correction needs
